The link between MHC class I abnormalities of tumors, oncogenes, tumor suppressor genes, and transcription factors

References

• Atkins, D., Ferrone, S., Schmahl, G. E., et al. 2004. Down-regulation of HLA class I antigen processing molecules: An immune escape mechanism of renal cell carcinoma? J. Urol. 171:885–889
   PubMed Web of Science ®Google Scholar
• Bukur, J., Herrmann, F., Handke, D., et al. 2010. Identification of E2F1 as an important transcription factor for the regulation of tapasin expression. J. Biol. Chem. 285:30419–30426
   PubMed Web of Science ®Google Scholar
• Ferris, R. L., Whiteside, T. L., and Ferrone, S. 2006. Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer. Clin. Cancer Res. 12:3890–3895
   PubMed Web of Science ®Google Scholar
• Jensen, P. E. 2007. Recent advances in antigen processing and presentation. Nat. Immunol. 8:1041–1048
   PubMed Web of Science ®Google Scholar
• Kageshita, T., Hirai, S., Ono, T., et al. 1999. Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: Association with disease progression. Am. J. Pathol. 154:745–754
   PubMed Web of Science ®Google Scholar
• Khan, A. N., Gregorie, C. J., and Tomasi, T. B. 2008. Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes, and MHC class I antigen presentation by melanoma cells. Cancer Immunol. Immunother. 57:647–654
   PubMed Web of Science ®Google Scholar
• Mehta, A. M., Jordanova, E. S., Kenter, G. G., et al. 2008. Association of antigen processing machinery and HLA class I defects with clinico-pathological outcome in cervical carcinoma. Cancer Immunol. Immunother. 57:197–206
   PubMed Web of Science ®Google Scholar
• Meissner, M., Reichert, T. E., Kunkel, M., et al. 2005. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: Association with clinical outcome. Clin. Cancer Res. 11:2552–2560
   PubMed Web of Science ®Google Scholar
• Nie, Y., Yang, G., Song, Y., et al. 2001. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas. Carcinogenesis 22:1615–1623
   PubMed Web of Science ®Google Scholar
• Norell, H., Carlsten, M., Ohlum, T., et al. 2006. Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunity. Cancer Res. 66:6387–6394
   Google Scholar
• Respa, A., Bukur, J., Ferrone, S., et al. 2011. Association of IFNγ signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines. Clin. Cancer Res. 17:2668–2678
   PubMed Web of Science ®Google Scholar
• Rock, K. L., York, I. A., and Goldberg, A. L. 2004. Post-proteasomal antigen processing for major histocompatibility complex class I presentation. Nat. Immunol. 5:670–677
   PubMedGoogle Scholar
• Romero, J. M., Jiménez, P., Cabrera, T., et al. 2005. Coordinated down-regulation of the antigen presentation machinery and HLA class I/β2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer. Int. J. Cancer 113:605–610
   PubMed Web of Science ®Google Scholar
• Saveanu, L., Carroll, O., Lindo, V., et al. 2005. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat. Immunol. 6:689–697
   PubMed Web of Science ®Google Scholar
• Seliger, B. 2008. Different regulation of MHC class I antigen processing components in human tumors. J. Immunotoxicol. 5:361–367
   PubMed Web of Science ®Google Scholar
• Seliger, B., Maeurer, M. J., and Ferrone, S. 2000. Antigen-processing machinery breakdown and tumor growth. Immunol. Today 21:455–464
   PubMedGoogle Scholar
• Seliger, B., Ritz, U., and Ferrone, S. 2006. Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation. Int. J. Cancer 118:129–138
   PubMed Web of Science ®Google Scholar
• Seliger, B., Stoehr, R., Handke, D., et al. 2010. Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer. Cancer Immunol. Immunother. 59:529–540
   PubMed Web of Science ®Google Scholar
• Sigalotti, L., Fratta, E., Coral, S., et al. 2004. Intra-tumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2′-deoxycytidine. Cancer Res. 64:9167–9171
   PubMed Web of Science ®Google Scholar
• Tanaka, K., Tsuchikawa, T., Miyamoto, M., et al. 2012. Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients. Int. J. Oncol. 40:965–974
   PubMed Web of Science ®Google Scholar
• Vitale, M., Rezzani, R., Rodella, L., et al. 1998. HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions. Cancer Res. 58:737–742
   PubMed Web of Science ®Google Scholar
• York, I. A., Goldberg, A. L., Mo, X. Y., and Rock, K. L. 1999. Proteolysis and class I major histocompatibility complex antigen presentation. Immunol. Rev. 172:49–66
   PubMed Web of Science ®Google Scholar